ARE 最新10-Q变化
将 ARE 最新的定期申报(10-K/10-Q)与上一份同类型申报逐章节对比:每个章节新增/删除的段落数与原文摘录。全部为确定性文本对比——无相似度评分、无方向判断、非投资建议。
对比:10-Q · 2026-10-26 与上一份 10-Q · 2026-08-03
| 章节 | 结果 | 新增 | 删除 | 微调 | 未变 |
|---|---|---|---|---|---|
| 管理层讨论与分析 | 文字有新增/删除 | +488 | −407 | ~302 | 847 |
| 市场风险(第3项) | 文字有新增/删除 | +3 | −4 | ~14 | 21 |
| 控制与程序 | 文字有新增/删除 | 0 | 0 | ~5 | 2 |
| 法律诉讼 | 文字有新增/删除 | +3 | −2 | ~2 | 13 |
| 风险因素 | 公司称无重大变化(指向 10-K) | — | — | — | — |
| 其他信息 | 文字有新增/删除 | +3 | −12 | 0 | 0 |
计数单位为段落;"新增/删除"指相对上一份文件新增/删除的文字,不含方向或好坏判断。
代表性摘录
每个章节最多 5 条、每条约 300 字符的原文摘录,直接来自两份 SEC 文件。
管理层讨论与分析
相对上期新增的文字 · 来源:10-Q · 2026-10-26
(1)Includes $637.9 million of real estate impairment charges related to assets held for sale for the three months ended September 30, 2026. Refer to Note 3 – “Investments
in real estate” to our unaudited consolidated financial statements in Item 1 for additional details.
•Target for the three months ending December 31, 2026, annualized: 5.6x–6.2x.
•For the three months ended September 30, 2026 annualized: 6.9x; 6.6x on a pro forma basis reflecting the October 2026
closing of the sale of our partial interest in the Campus Point by Alexandria joint venture.
相对上期删除的文字 · 来源:10-Q · 2026-08-03
(1)Refer to “Tenant collections” under “Definitions and reconciliations” for additional details.
•Net debt and preferred stock to Adjusted EBITDA of 7.0x and fixed-charge coverage ratio of 3.3x for the three months ended
June 30, 2026 annualized; the respective targets for the three months ending December 31, 2026, annualized, are 5.6x–6.2x
•We expect improvement in our quarter-annualized net debt and preferred stock to Adjusted EBITDA ratio in the second
half of 2026 as we complete dispositions, sales of partial interests, and other capital sources.
市场风险(第3项)
相对上期新增的文字 · 来源:10-Q · 2026-10-26
and variable-rate debt as of September 30, 2026 (in thousands):
Our exposure to market risk elements for the nine months ended September 30, 2026 was consistent with the risk elements
presented above, including the effects of changes in interest rates, equity prices, and foreign currency exchange rates.
相对上期删除的文字 · 来源:10-Q · 2026-08-03
The sensitivity analyses assume a parallel shift of all foreign currency exchange rates with respect to the U.S. dollar; however,
foreign currency exchange rates do not typically move in such a manner, and actual results may differ materially.
Our exposure to market risk elements for the six months ended June 30, 2026 was consistent with the risk elements presented
above, including the effects of changes in interest rates, equity prices, and foreign currency exchange rates.
法律诉讼
相对上期新增的文字 · 来源:10-Q · 2026-10-26
securities between January 30, 2024 and December 5, 2025. On September 10, 2026, the Court granted defendants’ motion to dismiss
the amended complaint with leave to amend. On October 15, 2026, the plaintiffs filed a second amended complaint.
the dismissal of the securities class action with prejudice or the denial of any motion to dismiss in the securities class action.
相对上期删除的文字 · 来源:10-Q · 2026-08-03
between January 30, 2024 and December 5, 2025. The defendants moved to dismiss the action on May 20, 2026.
resolution of any motion to dismiss in the securities class action.
其他信息
相对上期新增的文字 · 来源:10-Q · 2026-10-26
During the three months ended September 30, 2026, none of our officers or directors adopted or terminated any contract,
instruction, or written plan for the purchase or sale of our securities that was intended to satisfy the affirmative defense conditions of
Rule 10b5-1(c) or any “non-Rule 10b5-1 trading arrangement.”
相对上期删除的文字 · 来源:10-Q · 2026-08-03
On June 17, 2026, Marc E. Binda, our Chief Financial Officer and Treasurer, terminated a Rule 10b5-1 trading arrangement
that he had previously adopted in December 2025 for the sale from time to time of up to 23,368 shares of common stock. The trading
arrangement was intended to satisfy the affirmative defense conditions of Securities Exchange Act Rule 10b5-1(c) and was scheduled
On June 18, 2026, Hallie E. Kuhn, our Executive Vice President – Capital Markets and Co-Lead – Life Science, terminated a
Rule 10b5-1 trading arrangement that she had previously adopted in December 2025 for the sale from time to time of up to 2,574
如何读 10-Q 的风险因素(第 1A 项)
10-Q 的风险因素章节有三种常见形态,本页按其一分类展示:
- 指向(pointer) — 公司仅声明"无重大变化"并指向年度 10-K 的完整风险因素;本季没有自己的风险文本可对比。
- 部分更新(partial) — 公司写明"除下述外无重大变化",只更新部分风险;摘录展示的正是本季新增的内容。
- 全文重述(restated) — 本季重新给出完整风险因素。若上一季只是"指向",则无法逐段对比,本页会将其标为"本季全文重述"。
这只是对文件结构的客观描述,不构成对风险高低的判断。
数据来自 SEC EDGAR 两份申报文件的文本级对比 · 确定性计算(无 AI 生成内容)· 仅供参考 · 非投资建议